Singapore, Jan. 28 -- Swiss firm SpiroChem AG and Japan-based Veritas In Silico Inc. have announced the signing of a Memorandum of Understanding (MoU) to collaborate on the discovery and experimental validation of RNA modulating chemical matter. The collaboration brings together VIS's advanced artificial intelligence (AI) driven RNA design platform with SpiroChem's world class macrocycle, peptide and peptoid chemistry capabilities.

Published by HT Digital Content Services with permission from BioSpectrum Asia....